[Asia Economy Reporter Lim Ju-hyung] Albert Bourla, CEO of the American pharmaceutical company Pfizer, congratulated Moderna, a competitor, on the news that its COVID-19 vaccine showed 94.5% efficacy.


On the 16th (local time), CEO Bourla said, "I am thrilled to hear the good news from Moderna's COVID-19 vaccine development program."



He added, "We share the goal of defeating this terrible disease, and today we congratulate everyone at Moderna and share the joy of their encouraging results."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing